Within the framework of International R&D Nuclis call organized by ACCIÓ, Cytes Biotechnologies has been chosen as a success case for having won the grant that will promote its expansion and international growth.

For this reason, Jordi Xapelli, CEO of Cytes Biotechnologies, SL participated in a talk that took place last Friday, July 17th, where he explained the progress of the project in which the company is involved within this framework.

The aim of this talk was to promote the realization of R+D activities carried out in Catalonia and to facilitate international technological cooperation with foreign entities.

Fuente: CYTES BIOTECHNOLOGIES, SL.

https://www.cytesbiotechnologies.com/acci%C3%B3
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream